企業プロフィール
Smith and Nephew 株価・ニュース・カタリスト
- ティッカー:
- SNN
- 取引所:
- NYSE
- セクター:
- MedTech
- 所在地:
- United Kingdom and listed in the U
株価パフォーマンス
29.04 USD (-0.92%)
終値
最終更新: 2026年8月20日
12.5B USD
時価総額
株価変動の要因
As of Aug 20, 2026, SNN closed down 0.92% at $29.04. No new same-company headline was identified in the current news window.
企業概要
事業概要
Smith & Nephew is a global medical technology company focused on orthopedics, sports medicine, and advanced wound management. Its business is driven by procedure-linked demand and product innovation across surgical and restorative care.
所在地とセクター分類
Headquartered in the United Kingdom and listed in the U.S. as an ADR, Smith & Nephew has a broad international footprint. It sits in medtech rather than biotech.
ビジネスモデルの特徴
The company earns revenue through implants, surgical systems, wound care, and related products used in hospitals and clinics. Investors watch procedure volumes, product launches, and margin trends across its core franchises.
バイオ業界での位置付け
Smith & Nephew is outside biotech but important within healthcare technology because it benefits from surgical and wound-care demand. It tends to move on clinical adoption and hospital utilization rather than drug events.
今後のカタリスト
- Smith & Nephew’s watchpoints are robotics adoption, sports-medicine execution, and continued recovery in orthopedics. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。